Given CMBM’s less-than-impressive operating performance in recent quarters, we understand why the market would be skeptical. But with the two…
Read More »Supplementary
Net sales in the first quarter of 2024 rose 8.2% year-over-year to $135.1 million with all of its businesses contributing…
Read More » RCMT reported revenue of $71.9 million for the first quarter of 2024, which was up 7.2% from the prior year.…
Read More » AUDC reported a 1.5% year-over-year rise in Q1 revenue to $60.1 million. While Products segment revenue fell 0.5% to $28.6…
Read More » Hurt by an 11.3% decline in comparable sales, net sales in the first quarter of 2024 were down 10.9% from…
Read More » Buoyed by organic growth of 9% in Digestive Health, which benefited from the persistence of strong demand for NeoMed from…
Read More » FORR reported a 12.0% decline in Q1 revenue from the prior year to $100.1 million. Research segment revenue was lower…
Read More » Since our last review on February 20, CMBM has lost 23% of its value with essentially all of this additional…
Read More » Shares of PPC have fared well since out last review on February 26, rising about 12% compared to just a…
Read More » Q4 net sales rose 8.0% from the prior year to $172.2 million. This was led by growth of 22.2% and…
Read More »